Condition : Arthritis, Rheumatoid Interventions : Drug: Part 1: Etoricoxib 60 mg; Drug: Part 1: Etoricoxib 90 mg; Drug: Part 2: Etoricoxib 60 mg; Drug: Part 2: Etoricoxib 90 mg; Drug: Part 1: Placebo...

Condition : Spondylitis, Ankylosing Interventions : Drug: Part I - etoricoxib 60 mg; Drug: Part I - etoricoxib 90 mg; Drug: Part I- naproxen 1000 mg; Drug: Part I - Placebo to etoricoxib 60 mg; Drug:...

Condition : Osteoarthritis, Hip Interventions : Other: Supervised progressive resistance training; Other: Control group Sponsors : University of Aarhus; Regionshospitalet Silkeborg Completed - verifie...

Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks Sponsor : Eli Lilly and Company Recruiting - verified July 2011

Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks Sponsor : Eli Lilly and Company Recruiting - verified July 2011

Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks Sponsor : Eli Lilly and Company Recruiting - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 4 weeks; Drug: Placebo every 2 weeks Sponsor : Eli Lilly and Company Recruiting - verified August 2011

Condition : Arthritis, Psoriatic Interventions : Drug: RO5310074; Drug: Placebo Sponsor : Hoffmann-La Roche Recruiting - verified July 2011

Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 2 weeks; Drug: Placebo every 4 weeks Sponsor : Eli Lilly and Company Recruiting - verified July 2011

Condition : Rheumatoid Arthritis Interventions : Drug: LY2127399; Drug: Placebo every 2 weeks; Drug: Placebo every 4 weeks Sponsor : Eli Lilly and Company Recruiting - verified August 2011